Your search history is turned on.
Date: April 5, 2024 Jurisdictions: Alberta, British Columbia, Ontario
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Ontario
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers fro...
Date: November 15, 2023 Jurisdictions: Alberta, British Columbia, Ontario
StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update TORONTO, ON / November 15, 2023 /StageZero Life Sciences (StageZero or the Company) (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi- cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, ...
Date: November 14, 2023 Jurisdictions: Alberta, British Columbia, Ontario
1 StageZero Life Sciences Ltd. Nine-month periods ended September 30, 2023 and 2022 Unaudited, condensed consolidated interim financial statements and associated notes [Expressed in US dollars, unless otherwise noted] ...
STAGEZERO LIFE SCIENCES LTD. MANAGEMENTS DISCUSSION AND ANALYSIS For the three month and nine month periods ended September 30, 2023 and 2022 [Expressed in US dollars unless otherwise noted] The following discussion and analysis (MD&A) provides managements perspective on the financial position and results of operations of StageZero Life Sciences ...
Form 52-109F2 Certification of Interim Filings Full Certificate 1 I, James R. Howard-Tripp, the Chairman and Chief Executive Officer of StageZero Life Sciences Ltd. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of StageZero Life Sciences Ltd. (the issuer) for the interi...
StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA Aristotle and AVRT to be offered to My One Medical Sources Customer Base TORONTO, ON / ACCESSWIRE / November 14, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company wi...
StageZero Life Sciences Clinical Business Introduces Fourth Pillar to Cancer Offerings. Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patients. TORONTO, ON / ACCESSWIRE / November 7, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated he...
StageZero Life Sciences Clinical Business Introduces Third Pillar to Cancer Offerings. CareOncology partners with The Source Functional Nutrition to offer nutritional guidance to cancer patients. TORONTO, ON / ACCESSWIRE / October 20, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically ...